Molecular Biology of Liver Ischemia/Reperfusion Injury: Established Mechanisms and Recent Advancements

Surgical Clinics of North America

Volumn 90, Issue 4, 2010, Pages 665-677

  Klune, John R ^a   Tsung, Allan ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Hepatic; HMGB1; Ischemia reperfusion; Liver; Reactive oxygen species; TLR4

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BACTERIUM LIPOPOLYSACCHARIDE; BILIRUBIN; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; HIGH MOBILITY GROUP B1 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE; REACTIVE OXYGEN METABOLITE; TLR4 PROTEIN, HUMAN;

COLD ISCHEMIA; CYTOKINE PRODUCTION; ENZYME DENATURATION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; KUPFFER CELL; LIPID PEROXIDATION; LIVER ISCHEMIA; LYMPHOCYTE ACTIVATION; MOLECULAR BIOLOGY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; ANIMAL; APOPTOSIS; LIVER; LIVER CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CYTOKINES; HEPATOCYTES; HMGB1 PROTEIN; HUMANS; LIVER; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 4;

EID: 77954651382     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2010.04.003     Document Type: Review

References (112)

1. Bilzer M., Gerbes A.L. Preservation injury of the liver: mechanisms and novel therapeutic strategies. J Hepatol 2000, 32(3):508-515.
2. Caldwell-Kenkel J.C., Currin R.T., Tanaka Y., et al. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology 1989, 10(3):292-299.
3. Fan C., Zwacka R.M., Engelhardt J.F. Therapeutic approaches for ischemia/reperfusion injury in the liver. J Mol Med 1999, 77(8):577-592.
4. Lemasters J.J., Bunzendahl H., Thurman R.G. Reperfusion injury to donor livers stored for transplantation. Liver Transpl Surg 1995, 1(2):124-138.
5. McKeown C.M., Edwards V., Phillips M.J., et al. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation 1988, 46(2):178-191.
6. Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg 1998, 5(4):402-408.
7. Lentsch A.B., Kato A., Yoshidome H., et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000, 32(2):169-173.
8. Teoh N.C., Farrell G.C. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003, 18(8):891-902.
9. Jaeschke H., Farhood A., Smith C.W. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990, 4(15):3355-3359.
10. Jaeschke H., Smith C.V., Mitchell J.R. Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J Clin Invest 1988, 81(4):1240-1246.
11. Jaeschke H., Smith C.V., Mitchell J.R. Hypoxic damage generates reactive oxygen species in isolated perfused rat liver. Biochem Biophys Res Commun 1988, 150(2):568-574.
12. Semenza G.L. Cellular and molecular dissection of reperfusion injury: ROS within and without. Circ Res 2000, 86(2):117-118.
13. Wanner G.A., Ertel W., Muller P., et al. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 1996, 5(1):34-40.
14. Shirasugi N., Wakabayashi G., Shimazu M., et al. Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury. Transplantation 1997, 64(10):1398-1403.
15. Lentsch A.B., Yoshidome H., Kato A., et al. Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology 1999, 30(6):1448-1453.
16. Colletti L.M., Remick D.G., Burtch G.D., et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990, 85(6):1936-1943.
17. Colletti L.M., Burtch G.D., Remick D.G., et al. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 1990, 49(2):268-272.
18. Colletti L.M., Cortis A., Lukacs N., et al. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998, 10(3):182-191.
19. Colletti L.M., Kunkel S.L., Walz A., et al. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. J Clin Invest 1995, 95(1):134-141.
20. Lentsch A.B., Yoshidome H., Cheadle W.G., et al. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 1998, 27(4):1172-1177.
21. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 338(7):436-445.
22. Colletti L.M., Kunkel S.L., Walz A., et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1996, 23(3):506-514.
23. Lichtman S.N., Lemasters J.J. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Semin Liver Dis 1999, 19(2):171-187.
24. Yoshimura T., Matsushima K., Oppenheim J.J., et al. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1) 1987. J Immunol 2005, 175(9):5569-5574.
25. Hisama N., Yamaguchi Y., Ishiko T., et al. Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology 1996, 24(5):1193-1198.
26. Yoshidome H., Lentsch A.B., Cheadle W.G., et al. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice. J Surg Res 1999, 81(1):33-37.
27. Burke J., Zibari G.B., Brown M.F., et al. Hepatic ischemia-reperfusion injury causes E-selectin upregulation. Transplant Proc 1998, 30(5):2321-2323.
28. Sawaya D.E., Zibari G.B., Minardi A., et al. P-selectin contributes to the initial recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. Shock 1999, 12(3):227-232.
29. Singh I., Zibari G.B., Brown M.F., et al. Role of P-selectin expression in hepatic ischemia and reperfusion injury. Clin Transplant 1999, 13(1 Pt 2):76-82.
30. Yadav S.S., Howell D.N., Gao W., et al. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver. Am J Physiol 1998, 275(6 Pt 1):G1341-G1352.
31. Yadav S.S., Howell D.N., Steeber D.A., et al. P-Selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999, 29(5):1494-1502.
32. Farhood A., McGuire G.M., Manning A.M., et al. Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol 1995, 57(3):368-374.
33. Jaeschke H., Farhood A., Bautista A.P., et al. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 1993, 17(5):915-923.
34. Kuzume M., Nakano H., Yamaguchi M., et al. A monoclonal antibody against ICAM-1 suppresses hepatic ischemia-reperfusion injury in rats. Eur Surg Res 1997, 29(2):93-100.
35. Nakano H., Kuzume M., Namatame K., et al. Efficacy of intraportal injection of anti-ICAM-1 monoclonal antibody against liver cell injury following warm ischemia in the rat. Am J Surg 1995, 170(1):64-66.
36. Vollmar B., Glasz J., Menger M.D., et al. Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 1995, 117(2):195-200.
37. Li X.K., Matin A.F., Suzuki H., et al. Effect of protease inhibitor on ischemia/reperfusion injury of the rat liver. Transplantation 1993, 56(6):1331-1336.
38. Mavier P., Preaux A.M., Guigui B., et al. In vitro toxicity of polymorphonuclear neutrophils to rat hepatocytes: evidence for a proteinase-mediated mechanism. Hepatology 1988, 8(2):254-258.
39. Uchida Y., Freitas M.C., Zhao D., et al. The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl 2009, 15(8):939-947.
40. Jaeschke H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact 1991, 79(2):115-136.
41. Ozaki M., Deshpande S.S., Angkeow P., et al. Inhibition of the Rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo. FASEB J 2000, 14(2):418-429.
42. Otterbein L.E., Soares M.P., Yamashita K., et al. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003, 24(8):449-455.
43. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997, 37:517-554.
44. Ito K., Ikeda S., Shibata T., et al. Immunohistochemical analysis of heme oxygenase-I in rat liver after ischemia. Biochem Mol Biol Int 1997, 43(3):551-556.
45. Yamaguchi T., Terakado M., Horio F., et al. Role of bilirubin as an antioxidant in an ischemia-reperfusion of rat liver and induction of heme oxygenase. Biochem Biophys Res Commun 1996, 223(1):129-135.
46. Kato H., Amersi F., Buelow R., et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 2001, 1(2):121-128.
47. Kaizu T., Nakao A., Tsung A., et al. Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery 2005, 138(2):229-235.
48. Amersi F., Shen X.D., Anselmo D., et al. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 2002, 35(4):815-823.
49. Caldwell-Kenkel J.C., Currin R.T., Tanaka Y., et al. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology 1991, 13(1):83-95.
50. Gao W., Bentley R.C., Madden J.F., et al. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998, 27(6):1652-1660.
51. Chen T., Zamora R., Zuckerbraun B., et al. Role of nitric oxide in liver injury. Curr Mol Med 2003, 3(6):519-526.
52. Hur G.M., Ryu Y.S., Yun H.Y., et al. Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-kappaB. Biochem Biophys Res Commun 1999, 261(3):917-922.
53. Geller D.A., Nussler A.K., Di S.M., et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A 1993, 90(2):522-526.
54. Nussler A.K., Di S.M., Billiar T.R., et al. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 1992, 176(1):261-264.
55. Glantzounis G.K., Rocks S.A., Sheth H., et al. Formation and role of plasma S-nitrosothiols in liver ischemia-reperfusion injury. Free Radic Biol Med 2007, 42(6):882-892.
56. Lin H.I., Wang D., Leu F.J., et al. Ischemia and reperfusion of liver induces eNOS and iNOS expression: effects of a NO donor and NOS inhibitor. Chin J Physiol 2004, 47(3):121-127.
57. Katsumi H., Nishikawa M., Yasui H., et al. Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice. J Control Release 2009, 140(1):12-17.
58. Geller D.A., Chia S.H., Takahashi Y., et al. Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation. JPEN J Parenter Enteral Nutr 2001, 25(3):142-147.
59. Li S.Q., Liang L.J. Protective mechanism of L-arginine against liver ischemic-reperfusion injury in rats. Hepatobiliary Pancreat Dis Int 2003, 2(4):549-552.
60. Chattopadhyay P., Verma N., Verma A., et al. L-Arginine protects from pringle manoeuvere of ischemia-reperfusion induced liver injury. Biol Pharm Bull 2008, 31(5):890-892.
61. Taha M.O., Simoes M.J., Haddad M.A., et al. l-Arginine supplementation protects against hepatic ischemia-reperfusion lesions in rabbits. Transplant Proc 2009, 41(3):816-819.
62. Jeyabalan G., Klune J.R., Nakao A., et al. Arginase blockade protects against hepatic damage in warm ischemia-reperfusion. Nitric Oxide 2008, 19(1):29-35.
63. Reid K.M., Tsung A., Kaizu T., et al. Liver I/R injury is improved by the arginase inhibitor, N (omega)-hydroxy-nor-L-arginine (nor-NOHA). Am J Physiol Gastrointest Liver Physiol 2007, 292(2):G512-G517.
64. Albrecht E.W., Stegeman C.A., Heeringa P., et al. Protective role of endothelial nitric oxide synthase. J Pathol 2003, 199(1):8-17.
65. Duranski M.R., Elrod J.W., Calvert J.W., et al. Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006, 291(6):H2980-H2986.
66. Theruvath T.P., Zhong Z., Currin R.T., et al. Endothelial nitric oxide synthase protects transplanted mouse livers against storage/reperfusion injury: role of vasodilatory and innate immunity pathways. Transplant Proc 2006, 38(10):3351-3357.
67. Meguro M., Katsuramaki T., Nagayama M., et al. A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver. Transplantation 2002, 73(9):1439-1446.
68. Takamatsu Y., Shimada K., Yamaguchi K., et al. Inhibition of inducible nitric oxide synthase prevents hepatic, but not pulmonary, injury following ischemia-reperfusion of rat liver. Dig Dis Sci 2006, 51(3):571-579.
69. Tsuchihashi S., Kaldas F., Chida N., et al. FK330, a novel inducible nitric oxide synthase inhibitor, prevents ischemia and reperfusion injury in rat liver transplantation. Am J Transplant 2006, 6(9):2013-2022.
70. Kaizu T., Ikeda A., Nakao A., et al. Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival. Hepatology 2006, 43(3):464-473.
71. Hsu C.M., Wang J.S., Liu C.H., et al. Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock 2002, 17(4):280-285.
72. Matzinger P. Tolerance, danger, and the extended family. Annu Rev immunol 1994, 12:991-1045.
73. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296(5566):301-305.
74. Medzhitov R., Janeway C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997, 91(3):295-298.
75. Roth J., Vogl T., Sorg C., et al. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003, 24(4):155-158.
76. Scheibner K.A., Lutz M.A., Boodoo S., et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006, 177(2):1272-1281.
77. Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285(5425):248-251.
78. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999, 19(8):5237-5246.
79. Abraham E., Arcaroli J., Carmody A., et al. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165(6):2950-2954.
80. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5(4):331-342.
81. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418(6894):191-195.
82. Bonaldi T., Talamo F., Scaffidi P., et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003, 22(20):5551-5560.
83. Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 2003, 270(10):2109-2119.
84. Youn J.H., Shin J.S. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 2006, 177(11):7889-7897.
85. Tsung A., Klune J.R., Zhang X., et al. HMGB1 release induced by liver ischemia involves Tolllike receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007, 204(12):2913-2923.
86. Rendon-Mitchell B., Ochani M., Li J., et al. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 2003, 170(7):3890-3897.
87. Rouhiainen A., Kuja-Panula J., Wilkman E., et al. Regulation of monocyte migration by amphoterin (HMGB1). Blood 2004, 104(4):1174-1182.
88. Tang D., Shi Y., Kang R., et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 2007, 81(3):741-747.
89. Wahamaa H., Vallerskog T., Qin S., et al. HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay. J Leukoc Biol 2007, 81(1):129-136.
90. Andersson U., Wang H., Palmblad K., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000, 192(4):565-570.
91. Kokkola R., Andersson A., Mullins G., et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005, 61(1):1-9.
92. Orlova V.V., Choi E.Y., Xie C., et al. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 2007, 26(4):1129-1139.
93. Rouhiainen A., Tumova S., Valmu L., et al. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol 2007, 81(1):49-58.
94. Fan J., Li Y., Levy R.M., et al. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol 2007, 178(10):6573-6580.
95. Park J.S., Arcaroli J., Yum H.K., et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003, 284(4):C870-C879.
96. Park J.S., Svetkauskaite D., He Q., et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004, 279(9):7370-7377.
97. Hori O., Brett J., Slattery T., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995, 270(43):25752-25761.
98. Park J.S., Gamboni-Robertson F., He Q., et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006, 290(3):C917-C924.
99. Tsung A., Sahai R., Tanaka H., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005, 201(7):1135-1143.
100. Yamamoto T., Ono T., Ito T., et al. Hemoperfusion with a high-mobility group box 1 adsorption column can prevent the occurrence of hepatic ischemia-reperfusion injury in rats. Crit Care Med 2010, 38(3):879-885.
101. Ilmakunnas M., Tukiainen E.M., Rouhiainen A., et al. High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation. Liver Transpl 2008, 14(10):1517-1525.
102. Kumar H., Kawai T., Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009, 388(4):621-625.
103. Kaczorowski D.J., Tsung A., Billiar T.R. Innate immune mechanisms in ischemia/reperfusion. Front Biosci (Elite Ed) 2009, 1:91-98.
104. Shen X.D., Ke B., Zhai Y., et al. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 2005, 5(8):1793-1800.
105. Wu H.S., Zhang J.X., Wang L., et al. Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2004, 3(2):250-253.
106. Tsung A., Hoffman R.A., Izuishi K., et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005, 175(11):7661-7668.
107. Tsung A., Zheng N., Jeyabalan G., et al. Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol 2007, 81(1):119-128.
108. Hui W., Jinxiang Z., Heshui W., et al. Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury. Biochem Biophys Res Commun 2009, 389(2):328-332.
109. Shen X.D., Ke B., Zhai Y., et al. Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model. Liver Transpl 2007, 13(10):1435-1443.
110. Bamboat Z.M., Balachandran V.P., Ocuin L.M., et al. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 2010, 51(2):621-632.
111. Jin X., Wang L., Wu H.S., et al. N-Acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2007, 6(3):284-289.
112. Zhang J.X., Wu H.S., Wang H., et al. Protection against hepatic ischemia/reperfusion injury via downregulation of toll-like receptor 2 expression by inhibition of Kupffer cell function. World J Gastroenterol 2005, 11(28):4423-4426.